Sign up for kodicms's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.
Indian Stock Market News, Equity Market and Sensex Today in India | kodicms
  • MyStocks

Sensex Ends Near Record High; Realty Stocks Bleed
Thu, 18 Jan Closing | Monish Vora, TM Team

After opening the day on a strong note, share markets in India witnessed volatility during the last hour of trading session. However, they managed to end the day on a positive note. Losses were seen across most sectors with stocks in the telecom sector and stocks in the realty sector leading the losses. Banking stocks, on the other hand, traded in the green.

At the closing bell, the BSE Sensex stood higher by 178 points (up 0.5%) and the NSE Nifty closed up by 28 points (up 0.3%). Most of the selling pressure was seen for the BSE Mid Cap index, which ended the day down 1.7%, and the BSE Small Cap index which ended down by 2%.

Asian stock markets finished on a mixed note. As of the most recent closing prices, the Hang Seng was up by 0.43% and the Shanghai Composite was up by 0.91%. The Nikkei 225 was down by 0.44%. European markets were also trading mixed. The FTSE was down by 0.38%. The DAX stood up by 0.42%, while the CAC 40 was up by 0.17%.

The rupee was trading at Rs 63.83 against the US$ in the afternoon session.

In the news from the pharmaceuticals space, Suven Life Sciences has secured one product patent from China and one product patent from Sri Lanka corresponding to the New Chemical Entities (NCEs). The two patents are valid through 2033 and 2032 respectively.

The granted claims of the patents include the class of selective 5-HT4 and H3 compounds respectively.

These compounds are being developed as therapeutic agents for major depressive disorders and neurodegenerative disorders like Alzheimer's disease, Attention deficient hyperactivity disorder (ADHD), Huntington's disease, Narcolepsy, Parkinson and Schizophrenia respectively.

Just Released: Multibagger Stocks Guide
(2018 Edition)

In this report, we reveal four proven strategies to picking multibagger stocks.

Well over a million copies of this report have already been claimed over the years.

Go ahead, grab your copy today. It's Free.

NO-SPAM PLEDGE - We will NEVER rent, sell, or give away your e-mail address to anyone for any reason. You can unsubscribe from The 5 Minute WrapUp with a few clicks. Please read our & .

One must note that the innovators in the pharmaceutical industry rely heavily on patents. They make heavy use of patents whenever they create a new drug. The patent allows them to recoup the high capital expenditure that goes into the research and development (R&D) of new drugs. Also, companies that have a patent on a particular product are immune from competition for the duration of the patent.

Speaking of pharma companies, the BSE healthcare index was the worst performing sector in 2017. In fact, the sector has underperformed over the past three years.

While 2018 earnings of pharma companies are expected to be better considering the low earnings base in 2017, certain challenges still remain.

The valuations of the top five companies by market capitalization on BSE healthcare remain high. Average Price to Earnings Ratio of the top five companies stands at 36. Considering the headwinds these companies are facing, it certainly seems rich.

Valuations of Top Pharma Companies Still High

An improved earnings performance in 2017 will certainly get these valuations to reasonable levels, provided the share price remains the same. But, the headwinds for the sector still exists.

2018 looks likely to be another challenging year for the sector. The uncertainties make it important to be stock specific in the sector.

As of today, three stocks in the pharma sector are currently buy worthy according to The India Letter (subscription required). These are the pharma stocks we believe will outlast the others in the long run.

Moving on to the news from commodities space. India's gold imports rose 53% to 846 tonnes in the 2017 fiscal. This came mainly on the back of strong domestic demand and lower global prices.

Reportedly, India is world's second largest gold consumer and had imported 550 tonnes of the metal in 2016.

In December 2017 alone, gold imports rose to 70 tonnes from 49 tonnes in the year-ago period.

Further, global prices of gold remained lower between US$1,200 per ounce and US$1,300 per ounce. Currently, they are ruling higher at above Rs 1,330 per ounce level.

To keep a tab on the movements in gold and other commodities, you can read the stock market commentary from the Daily Profit Hunter team. Their commentary tracks the developments in the global economy as well as stock, currency, and commodity markets.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

kodicms requests your view! Post a comment on "Sensex Ends Near Record High; Realty Stocks Bleed". Click here!

Last Stoks

bse stock market watch software download dubai currency into indian rupees american dollars to indian rupees icici bank share price today jaypee group share price live nse prices infosys bse stock price jpassociat share price today sensex news today book on indian stock market value investing indian stocks


Jan 18, 2018 03:35 PM